AAD, Industry Collab to Increase Number of Black,Latino, and Indigenous Physicians in DermatologyApr 1, 20221 min readVolume 19, No. 4 • April 2022
Aquavit Receives FDA Clearance for Two INDs to Initiate Clinical Trials With Its Botulinum ToxinNEW YORK, April 29, 2023 /PRNewswire/ -- Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum...
Aquavit Files IND Application for its Flagship Intradermal Injection of Botulinum ToxinNEW YORK, April 28, 2023 /PRNewswire/ -- Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum...
WIPO Publishes Aquavit's Methods for Delivering Bioactive Compositions and Formulations to the SkinNEW YORK, March 23, 2023 /PRNewswire/ -- Aquavit Pharmaceuticals, Inc. (Aquavit), a biotechnology company focused on the development of a...
Comments